Background: Injecting drug use has historically been the principal driver of the HIV epidemic in the northeast states of India. However, recent data indicate growing numbers of people who inject drugs (PWIDs) in north and central Indian cities.
Introduction
The HIV epidemic in India has been propelled primarily by heterosexual transmission [1, 2] . Indian public health measures targeting female sex workers and highrisk heterosexual populations have yielded meaningful progress in the control of the HIVepidemic [3] . However, in light of the low prevalence of HIV in the general Indian population, the importance of monitoring trends among key populations -notably people who inject drugs (PWIDs) and men who have sex with men -has been emphasized as an essential need [1, 2] .
Estimates of the number of PWIDs in India vary by fivefold [4, 5] and geographic differences are substantial. Historically, injecting drug use has been the principal driver of the HIV epidemic in northeast states, where proximity to the 'golden triangle' of heroin production (Myanmar, Thailand, and Laos) has fueled much higher rates of injecting drug use than in other areas of the country [6, 7] . Recent studies have drawn attention to increases in drug injecting in north and central Indian states, with injection of buprenorphine and other pharmaceuticals predominating [8, 9] . High HIV prevalence rates have generally been reported among PWIDs in northeast Indian states and in major cities [10] [11] [12] [13] ; however, there are less data available on HIV burden among PWIDs in the north and central regions of India. As part of baseline data collection for a clusterrandomized trial (ClinicalTrials.gov Identifier: NCT01686750), we used respondent-driven sampling to collect demographic, behavioural, and laboratory data among PWIDs from 15 cities in India.
Methods

Setting and recruitment
We conducted a cross-sectional survey among PWIDs from sites in 15 cities ( Fig. 1 ), including seven sites in the northeast region (Aizawl, Churachandpur, Dimapur, Gangtok, Imphal, Lunglei, and Moreh), where injecting drug use is long established, and eight sites in north and central India (Amritsar, Bhubaneshwar, Bilaspur, Chandigarh, Kanpur, Ludhiana, Mumbai, and New Delhi) , where increases in injecting drug use have variably been reported. At each site, we partnered with nongovernmental organizations that provide services to PWIDs and conducted preliminary ethnographic work. We used respondent-driven sampling to recruit PWIDs, with the goal of recruiting 1000 participants from each site [14] [15] [16] . We initiated recruitment at each site with two or three 'seeds' -individuals identified in the ethnographic phase as well connected in the PWID communities.
Individuals were eligible to participate if they were 18 years or older, reported injecting drug use in the prior 2 years, provided verbal informed consent, and presented a valid recruitment coupon (except for the seeds). Each participant who completed the study was given two coupons to recruit other individuals from his or her network. Participants were reimbursed for participating in the study and for each eligible participant they recruited. Coupons were bar-coded to track recruitment chains and imprinted with a holographic image to hinder duplication. We also used a biometric system that converted fingerprint images to unique hexadecimal codes to prevent duplicate enrollment [16] .
Procedures
Trained interviewers administered a face-to-face structured survey that captured information on demographic factors, network size, drug (injecting and noninjecting) Among samples from the HIV-positive participants, we characterized recent HIV infection according to a multiassay algorithm that has been validated for HIV subtype C [18] -the predominant subtype in India [19] . The algorithm included four assays: CD4 þ cell count, HIV RNA level, Aware BED EIA HIV-1 Incidence Test (Calypte Biomedical Corporation, Portland, Oregon, USA), and an avidity-modified GS HIV-1/HIV-2 PLUS O EIA kit (BioRad Laboratories, Redmond, California, USA) using diethyl amine as the chaotropic agent. HIVpositive patients were considered recently infected if the CD4 þ cell count was greater than 200 cells/ml, HIV RNA was above 400 copies/ml, BED-CEIA was below 1.0 normalized optical density, and avidity index was below 80%.
Statistical analysis
We assessed the occurrence of equilibrium during recruitment (the tendency for covariate proportions to stabilize with successive recruitment waves) and homophily (the tendency of participants to recruit individuals with similar characteristics) according to HIV status and other factors [15] . We excluded data from 'seed' participants from the analyses. We used the Volz-Heckathorn estimator, which weights estimates for network size (number of PWIDs in the city whom the participant saw in the prior 30 days), to calculate site-level estimates of demographic, behavioral, and clinical characteristics [20] . HIV prevalence was defined by dividing the number of HIV-positive participants by the total population at each site, incorporating Volz-Heckathorn weights. Annualized HIV incidence (I) was estimated at each site using the following equation:
where w is the number of HIV-positive patients determined to have recent infection by the multiassay algorithm, n is the number of HIV-negative patients, and m is the window period in years (0.56), which was based on prior optimization for HIV serotype C [18] . Incidence estimates were not weighted.
We compared participant characteristics from the seven northeast sites with eight sites in north and central India.
Estimates for continuous and categorical variables were expressed as the median of site medians and the median site percentage, respectively, with site-level ranges. We identified correlates of prevalent HIV using multilevel logistic regression models and correlates of recent HIV infection using multilevel Poisson regression models, both of which included random intercepts for each site (to account for clustering) and incorporated sample sizescaled Volz-Heckathorn sampling weights. For the prevalence analysis, we considered primarily lifetime risk factors, and for the recent HIV infection analysis, we focused on risk behaviors reported in the prior 6 months. Factors that were associated with HIV prevalence or incidence at P less than 0.10 in univariate analysis were considered for inclusion in multivariate models. With the exception of age and region, which were included regardless of statistical significance, only those variables associated with the outcome at P less than 0.05 were retained in the final multivariable models. We tested for interactions between covariates by combining terms in regression models. Additionally, we assessed the sensitivity of our conclusions to the weighting scheme by also fitting unweighted models and models weighted the Salganik-Heckathorn estimator [21] . We used RDS Analyst Software version 0.1 (http://hpmrg.org) and STATA version 12.0 (STATA Corp., College Station, Texas, USA) for analyses.
Ethical oversight
The study was approved by the institutional review boards of YRGCARE in Chennai, India, and Johns Hopkins University School of Medicine in Baltimore. The study survey participants provided verbal informed consent.
Results
We conducted surveys among PWIDs in 15 Indian sites between January and December 2013. A total of 14 481
PWIDs were recruited -approximately 1000 participants per site (Table 1 ) -with the exception of Moreh, where we discontinued recruitment after enrolling 459 participants because of civil unrest. A typical respondent-driven sampling recruitment diagram is shown in Fig. S1 (supplemental digital content, http://links.lww.com/ QAD/A643). Across sites, the median (range) time to complete recruitment was 135 days (52, 200) and the median (range) number of recruitment waves was 22, (12, 50) (Table S1 , supplemental digital content, http:// links.lww.com/QAD/A642). In general, homophily values for HIV status were low, meaning that participants were only marginally more likely than chance to recruit someone with the same HIV status as themselves. g See text for methods.
Regional and city variability
Characteristics of PWIDs in northeast sites are compared with north/central sites with weighted site-level estimates (medians and percentages) ( Table 2) . Female PWIDs were almost exclusively recruited from northeast sites. The vast majority of participants across both regions reported injecting in the preceding 6 months. Heroin was the predominant drug injected in the northeast, whereas buprenorphine was the predominant drug injected in north/central sites, with minorities injecting other pharmaceuticals or heroin. However, there were exceptions to regional trends in drugs injected. For example, in the northeast, injection of nonbuprenorphine pharmaceutical opioids predominated in the sites at Dimapur, Gangtok, and Lunglei. Additionally, 85% of PWIDs in the large port city of Mumbai reported heroin injection in the prior 6 months, compared with much lower rates in other north/central sites. Injection of cocaine or other 
HIV prevalence
Across the 15 sites, a total of 2905 participants tested positive for HIV, for a median weighted site-level HIV prevalence of 18.1% (range 5.9-44.9%). Site-level estimates of HIV prevalence and incidence are shown in Table 1 and Fig. 1 . Unweighted site-level prevalence estimates and 95% confidence intervals (CIs) are shown in Table S3 (supplemental digital content, http://links.lww. com/QAD/A642). Compared with the northeast sites, HIV prevalence was lower in north/central sites, although not statistically significantly so after adjustment for other factors (Table 3) .
HIV prevalence was substantially higher in women than men. In the northeast sites, where women accounted for greater than 5% of the PWIDs recruited, the HIV prevalence was 53.2% in women compared with 18.2% among men (P < 0.01). In a multivariate model that included all sites, women had over three-fold higher odds of HIV infection compared with men ( Table 3 ). Higher educational attainment was negatively associated with prevalent HIV infection. Duration since initiation of injecting and history of sharing needles or syringes were also strongly associated with increased odds of prevalent HIV infection. Participants who injected pharmaceuticals or both heroin and pharmaceuticals had increased odds of HIV compared with those who exclusively injected heroin. Hazardous or higher levels of alcohol use were negatively associated with HIV infection. History of 624 AIDS 2015, Vol 29 No 5 Hazardous use defined by score at least 8 on Alcohol Use Disorder Identification Test (AUDIT) and dependence defined by AUDIT score at least 15 [17] . c Ever use of needle exchange program did not remain statistically significant after adjustment for other correlates; therefore, it was not included in the multivariate model.
incarceration was associated with more than two-fold increased odds of prevalent HIV. A history of exchanging sex for money or goods had a borderline statistically significant association with higher HIV prevalence in univariate analysis, but not in multivariate analysis. The odds ratios (ORs) for commercial sex and HIV prevalence were similar in men and women (1.22 and 1.56, respectively). Use of opioid-substitution treatment or needle-exchange services was associated with increased odds of prevalent HIV in univariate analysis, but not after adjustment for other factors.
HIV incidence
Of the 2905 HIV-positive patients, 155 (5.3%) met laboratory criteria for recent infection. In contrast to HIV prevalence, HIV incidence tended to be higher in north/ central sites compared with northeast sites [median (range) 2.9 per 100 person-years (0, 12.4) versus 1.0 per 100 person-years (0, 3.4), respectively], although the difference was not statistically significant. The four sites with the highest HIV incidence among PWIDs were in the north/central region, and one of these sites (Kanpur) had an HIV incidence that was over twice as high as the next highest site (Fig. 1) .
Considering individual-level factors and risk of recent HIV infection, there was no association between sex and recent HIV infection in univariate analysis (Table 4 ). However, there was evidence of effect modification between sex and marital/partner status, whereby a married or cohabitating status was associated with a substantially increased risk of recent infection in women, Interaction term between sex and marital status statistically significant in univariate (P ¼ 0.003) and multivariate analysis (P ¼ 0.018). c Hazardous use defined by score at least 8 on Alcohol Use Disorder Identification Test (AUDIT) and dependence defined by AUDIT score at least 15 [17] .
but had a protective or null association in men (P ¼ 0.003 and P ¼ 0.018 for interaction terms in univariate and multivariate models, respectively). While recent injecting frequency was not significantly associated with the risk of recent HIV infection, using needles/syringes after larger numbers of individuals in the prior 30 days was associated with recent HIV infection in a dose-dependent manner. Compared with reporting no sex partners in the prior 6 months, having one or two to three partners were associated with significantly lower risks of recent HIV infection. Moreover, this protective association between sex partners and recent HIV infection was similar and statistically significant in both men and women (data not shown). The magnitude of the association changed little in the multivariate model, suggesting that having sex partners was not simply a surrogate for less risky injection practices. Similar to associations seen with prevalent HIV infection, injection of both heroin and pharmaceutical drugs was associated with increased risk of recent infection compared with injecting heroin alone, and high levels of alcohol use were associated with lower risk of recent HIV infection compared with no or low levels of alcohol use.
Discussion
The study -which collected data from 14 481 participants using respondent-driven sampling across sites in 15 Indian cities -is among the largest systematic epidemiological assessments of HIV burden among PWIDs in any country. We found high levels of lifetime and recent needle and syringe sharing, varying access to risk-reduction services and HIV testing, and a high burden of HIV, with a median weighted HIV prevalence of 18.1% across these sites. We were particularly interested in comparing northeast sites, where there is a longstanding link between injecting drug use and HIV, to north/central sites, where injecting drug use has emerged in recent years [8, 9] . HIV prevalence rates were higher in the northeast region compared with the north/central region. However, estimated HIV incidence rates tended to be higher in north/central sites compared with the northeast sites, with the four highest incidence rates in north/central sites, suggesting a growing HIV epidemic among PWIDs in these regions.
An important caveat to interpreting regional differences is high between-site variability, both across and within regions. Site-level HIV prevalence among PWIDs ranged from 5.9 to 44.9%, prior HIV testing ranged from 7.9 to 82%, and ever use of opioid substitution treatment ranged from 0 to 48.7%. This heterogeneity challenges the ability to provide meaningful nation-wide estimates of HIVrelated factors among PWIDs. However, our data suggest that the burden of HIV among PWIDs in India may be higher than previously estimated [1] .
People who inject drugs in the north/central site in Kanpur, Uttar Pradesh, had an HIV prevalence of 31% and an HIV incidence of 12.4 per 100 person-years -a value over twice as high as any other site. The scale of the HIV epidemic among PWIDs in Kanpur was surprising, as there were limited data on PWIDs in this city previously. However, a recent media report indicated that Kanpur had the third largest number of registered cases for drug-trafficking in 2012, following Mumbai and Delhi, supporting our finding of high HIV burden in this medium-sized city [22] . Access to needle/syringe exchange and opioid-substitution treatment was extremely low in Kanpur, and the rate of HIV testing was the lowest of all sites surveyed.
Participant-level correlates of HIV infection in our study were consistent with prior studies [10, 12] and included duration since first injection and lifetime history of sharing needles or syringes. Correspondingly, in the analysis of factors associated with recent HIV infection, we found that using needles/syringes after larger numbers of people in the previous 6 months was associated with recent HIV infection in a dose-response relationship, underscoring the importance of curtailing needle/syringe sharing in the public health approach to HIV prevention among PWIDs. Lifetime history of incarceration was also strongly associated with higher HIV prevalence, a risk factor which has been reported by other groups [23, 24] .
We found that female PWIDs, who were nearly exclusively encountered in the northeast, had a greater than three-fold higher odds of HIV than male PWIDs, supporting the findings of Mahanta et al. [10] . Preliminary ethnographic work by our team in the northeast revealed that female PWIDs are rejected by their families to a greater degree than male PWIDs, which may contribute to the vulnerability of these women. Although we did not find women to be at statistically significantly higher risk for 'recent' HIV infection than men, we found evidence of effect modification, whereby having a spouse or domestic partner was associated with significantly increased risk of recent infection in women but not in men, suggesting that transmission of HIV from a partner (either sexually or via injection behaviors) is a greater risk to female than to male PWIDs. Previous study has highlighted the high risk of sexual HIV transmission from men who inject drugs to their wives [24, 25] . Moreover, in a separate analysis from this study population, we found that female PWIDs had a significantly lower prevalence of hepatitis C infection compared with men (adjusted OR 0.32, 95% CI 0.12, 0.83), suggesting that the higher prevalence of HIV infection among women is not explained by more risky injecting practices [26] . However, we did not find strong evidence that selfreported data on sexual HIV risk behaviors (e.g. history of commercial sex work or number of recent sex partners) explained the observed HIV prevalence difference in male and female PWIDs.
Unexpectedly, we found that having up to three sex partners in the prior 6 months was associated with a lower risk of recent HIV infection, compared with having no recent sex partners -a finding that was similar and statistically significant in both men and women. Opioid addiction is consistently linked to hypogonadism and decreased libido [27] . So, recent sex partners may correlate with less intense or risky drug use, although we could find no clear indicator of such an association in the data. In both the analyses of HIV infection overall and of recent HIV infection, hazardous levels of alcohol use had a protective association with HIV infection. Higher levels of alcohol use may be a marker of less frequent or less risky injecting behavior. In a longitudinal study of PWIDs in Chennai, we found that cessation of injecting was associated with increases in hazardous levels of alcohol use [28] .
Our study has notable strengths. First, we used respondent-driven sampling -a strategy that is suited for 'hidden' populations and permits weighting to produce unbiased estimates of factors of interest in the target population. Second, we systematically surveyed PWIDs from sites in 15 Indian cities over the course of 1 year, which facilitated cross-site comparisons that were not confounded by methodological differences or temporal trends. Third, we recruited approximately 1000 PWIDs from each site, which provided precise estimates of factors of interest, even after accounting for the design effect of respondent-driven sampling compared with simple random sampling. Finally, our central reference laboratory used state-of-the-art methods to characterize recent HIV infection across sites, permitting HIV incidence estimates.
A limitation of our study was that we did not randomly select sites and regions for sampling and, consequently, our data should not be considered nationally representative. Notably, we did not survey southern cities, although our group has conducted epidemiologic work among PWIDs in Chennai previously [12, 28] . Additionally, we selected sites where we believed recruiting 1000 PWIDs would be feasible. A second limitation was that regional differences in HIV recombinant forms may have affected incidence estimates derived from our multiassay algorithm. HIV-1 subtype C predominates in India, but recombinant forms, which are rare overall, are more common in the northeast [19, 29] . However, most Indian recombinants described to date [29] have had a subtype C or subtype A-derived envelope gene, which has identical performance characteristics in the multiassay algorithm we used [18] . Finally, we did not collect detailed networklevel risk data.
In this respondent-driven sampling survey of 14 481 PWIDs from 15 Indian cities, we found high rates of lifetime and recent needle and syringe sharing, and a HIV prevalence above 10% in all but three sites. HIV prevalence tended to be lower, but HIV incidence higher, in north/central sites, where injecting drug use has emerged more recently than in the northeast, where injecting drug use is endemic. These data suggest that increases in injecting drug use outside of the northeast pose an emerging challenge to successful HIV control efforts in India. The finding that injecting pharmaceutical agents (with or without heroin) was associated with higher HIV risk compared with injecting heroin alone may suggest new public health approaches focusing on injected pharmaceuticals. Although rare outside of the northeast, women who inject drugs were at substantially higher risk for HIV than men. Risk-reduction strategies targeting women who inject drugs are needed.
